Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ApoScreen® Annexin V Apoptosis Kit-FITC

FACS, ICC
Produktnummer ABIN376221
497,84 €
Zzgl. Versandkosten 20,00 € und MwSt
100 tests
Lieferung nach: Deutschland
Lieferung in 7 bis 10 Werktagen

Kurzübersicht für ApoScreen® Annexin V Apoptosis Kit-FITC (ABIN376221)

Target

Alle Annexin V (ANXA5) Kits anzeigen
Annexin V (ANXA5) (Annexin A5 (ANXA5))

Applikation

Flow Cytometry (FACS), Immunocytochemistry (ICC)
  • Konjugat

    FITC

    Verwendungszweck

    ApoScreen® Annexin V Apoptosis Kit-FITC

    Produktmerkmale

    FITC ApoScreen® Annexin V Apoptosis Kit for use in flow cytometry and immunocytochemistry assays.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    E.coli expressed Annexin V

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Annexin V-FITC - Annexin V Binding Buffer PI - Annexin V Binding Buffer Annexin V Binding Buffer - Contains 0.1 % sodium azide and proprietary ingredients

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Protect conjugated products from light.
    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Lagerung

    4 °C

    Informationen zur Lagerung

    2-8°C
  • Rosso, Polotskaia, Bargonetti: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." in: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).

    Polotskaia, Hoffman, Krett, Shanmugam, Rosen, Bargonetti: "8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers." in: Molecular cancer therapeutics, Vol. 11, Issue 11, pp. 2495-504, (2012) (PubMed).

    Yan, Tan, Geng, Ju, Gao, Zhu: "Inhibition effect of siRNA-downregulated UHRF1 on breast cancer growth." in: Cancer biotherapy & radiopharmaceuticals, Vol. 26, Issue 2, pp. 183-9, (2011) (PubMed).

  • Target

    Annexin V (ANXA5) (Annexin A5 (ANXA5))

    Andere Bezeichnung

    Annexin V

    Hintergrund

    Optional[Description]: ApoScreen® Annexin V Apoptosis Kit-FITC
Sie sind hier:
Chat with us!